Subscribe: FT.com - Health
http://www.ft.com/rss/companies/drugs
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
big  cancer  companies  drug  elect  health  healthcare  new  president elect  president  pricing  research  sleep  survey  times  trump 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: FT.com - Health

Health



Latest drugs and health news



Published: Wed, 18 Jan 2017 12:03:30 GMT

Last Build Date: Wed, 18 Jan 2017 16:52:19 GMT

Copyright: © Copyright The Financial Times Ltd 2017. "FT" and "Financial Times" are trademarks of the Financial Times. See http://www.ft.com/servicestools/help/terms#legal1 for the terms and conditions of reuse.
 



US biotech Ovid to develop Takeda epilepsy drug

Wed, 18 Jan 2017 12:03:30 GMT

Unusual deal shows expanding role of smaller groups in bringing medicines to market



Pfizer warns of ‘big challenge’ from strong dollar

Wed, 18 Jan 2017 10:40:26 GMT

Earnings from US companies with big percentage of sales from overseas at risk



Drug companies pledge to improve EM cancer care

Wed, 18 Jan 2017 05:01:01 GMT

Efforts follow criticism of drug pricing and access in some of the poorest parts of the world



AstraZeneca expands trials for key cancer drug

Tue, 17 Jan 2017 13:54:39 GMT

Move gives company more options but could signal less confidence in initial approach



The problem with US healthcare in one chart

Tue, 17 Jan 2017 09:37:20 GMT

Americans spend five times more than Chileans, yet their lifespan is shorter



Healthcare: six big policy areas to watch

Tue, 17 Jan 2017 05:02:49 GMT

Tremors from political shake-ups in 2016 will be felt beyond country borders



Luxottica and Essilor eye connected vision with €50bn merger

Mon, 16 Jan 2017 18:36:49 GMT

Ray-Ban owner and lens-maker plot growth through technology and new markets



How toys can turn around global health

Mon, 16 Jan 2017 18:04:08 GMT

Whirligig research shows solutions to problems such as malaria may be under our noses



Profile: Essilor’s Hubert Sagnières

Mon, 16 Jan 2017 17:33:14 GMT

Dubbed the ‘chief evangelical officer’, the Frenchman is on profit-driven mission



Genedrive scores US army coup with DNA-testing deal

Mon, 16 Jan 2017 00:02:29 GMT

UK group to supply kits to detect biological warfare agents



Sleep deprivation can hit companies’ bottom lines

Sun, 15 Jan 2017 05:47:43 GMT

As working long hours becomes pervasive, a sleep coach advises how to rescue your rest



Overdone it over Christmas? Employers step in

Sun, 15 Jan 2017 05:47:16 GMT

Companies are capitalising on New Year’s resolutions to create healthier workforces



Time to sign up for Britain’s Healthiest Workplace survey

Sun, 15 Jan 2017 05:47:16 GMT

Winners’ names will be published, but survey will also help promote understanding



Drugmakers alarmed by Trump pricing threat

Sat, 14 Jan 2017 14:33:40 GMT

President-elect’s anti-vaccine rhetoric adds to concern among pharma executives



Week in Review, January 14

Fri, 13 Jan 2017 22:14:24 GMT

UK retailers, currency traders, investment bankers, UniCredit and the President-elect



UK blue chips could clear pension holes with one year’s dividends

Fri, 13 Jan 2017 20:58:24 GMT

FTSE 100 payouts 5 times bigger than scheme contributions, research finds



Memo to May: the NHS must have more money

Fri, 13 Jan 2017 19:25:30 GMT

She is wrong on the health service and only extra funding will solve short-term ills



Trump vow on high drug prices taps into public anger

Thu, 12 Jan 2017 18:26:16 GMT

President-elect embraces popular issue as Congress moves to dismantle Obamacare



HIV diagnoses falls steeply, data show

Thu, 12 Jan 2017 17:03:53 GMT

London clinics see hope in increased use of pre-exposure prophylaxis



Sanofi confident it can overturn Praluent ruling

Thu, 12 Jan 2017 16:56:01 GMT

French drugmaker faces questions over how to offset declining Lantus revenues